Alopecia Archives - MDNewsline

One of the most extensive epidemiological investigations in the last five decades regarding alopecia areata prevalence and incidence in the United States shows that the burden of the condition is rising, disproportionately affecting females and people living in the Northeast.

Alopecia Dermatology Immunology

U.S. Trends in Prevalence and Incidence of Alopecia Areata

One of the most extensive epidemiological investigations in the last five decades regarding alopecia areata…

MDNewsline DailySeptember 29, 2023

A new study found that Blacks and Hispanics are much more likely to be affected by alopecia areata than Whites. The study also found that, due to a lack of access to healthcare, people from lower education and income groups are less likely to be diagnosed with alopecia areata.

Alopecia Dermatology Health Disparities Immunology

Insights From the ‘All of Us’ Alopecia Research Program

A new study found that Blacks and Hispanics are much more likely to be affected…

MDNewsline DailySeptember 29, 2023

A recent study provides unique insights into alopecia areata presentation in Hispanic/Latinx patients. It found that comorbidities and nutritional deficiencies were common in the group.

Alopecia Dermatology Health Disparities Uncategorized

Understanding Alopecia Areata Epidemiology in Hispanic/Latinx Patients

A recent study provides unique insights into alopecia areata presentation in Hispanic/Latinx patients. It found…

MDNewsline DailySeptember 29, 2023

A retrospective study reports that when enrolling patients for alopecia areata clinical trials, Blacks are likelier to fail initial screening and have higher withdrawal or early termination rates.

Alopecia Dermatology Health Disparities Immunology

Understanding Causes of Racial Disparities in Alopecia Areata

A retrospective study reports that when enrolling patients for alopecia areata clinical trials, Blacks are…

MDNewsline DailySeptember 29, 2023

The pathogenesis of stress-induced alopecia areata involves apoptotic and autoimmune pathways that may interact with one another in the development of the disease, serving as potential therapeutic targets.

Alopecia Dermatology Skin of Color Update (SOCU) 2023

Psychological Stress and the Development of Alopecia Areata

The pathogenesis of stress-induced alopecia areata involves apoptotic and autoimmune pathways that may interact with…

MDNewsline DailyAugust 18, 2023

Oral Janus kinase inhibitors such as brepocitinib, baricitinib, deuruxolitinib, and ritlecitinib are effective for the treatment of alopecia areata, causing significant regrowth of hair with only mild to moderate adverse effects.

Alopecia Dermatology Skin of Color Update (SOCU) 2023

Ideal JAK Inhibitor for Alopecia Areata

Oral Janus kinase inhibitors such as brepocitinib, baricitinib, deuruxolitinib, and ritlecitinib are effective for the…

MDNewsline DailyAugust 18, 2023

People with alopecia areata have gender-specific comorbidities, including anxiety, dermatitis, hypothyroidism, and hyperlipidemia. According to a recent study, interactions between gender, age, and the severity of the disease influence the onset of these associated diseases.

Alopecia Dermatology Skin of Color Update (SOCU) 2023

Age and Sex Affect Alopecia Areata Comorbidities

People with alopecia areata have gender-specific comorbidities, including anxiety, dermatitis, hypothyroidism, and hyperlipidemia. According to…

MDNewsline DailyAugust 18, 2023

$Combination therapy using local corticosteroids and fractional erbium YAG laser was found to be an effective treatment method for alopecia areata.$

Alopecia Dermatology Skin of Color Update (SOCU) 2023

Topical Steroids With Fractional Erbium YAG Laser in Alopecia Areata

Combination therapy using local corticosteroids and fractional erbium YAG laser was found to be an…

MDNewsline DailyAugust 18, 2023

Ritlecitinib showed good efficacy and safety for alopecia areata treatment in adolescents in this study.

Alopecia Dermatology Pediatrics Skin of Color Update (SOCU) 2023

Effectiveness and Safety of Ritlecitinib in Adolescents With Alopecia Areata

Ritlecitinib showed good efficacy and safety for alopecia areata treatment in adolescents in this study.…

MDNewsline DailyAugust 18, 2023

For treating patients with chronic pruritus, narrowband ultraviolet B was found to be equivalent to broadband ultraviolet B.

Alopecia Atopic dermatitis Dermatology Skin of Color Update (SOCU) 2023 Vitiligo

Treatment of Chronic Pruritus: Narrowband UVB vs. Broadband UVB

Medically reviewed by Dr. Samuel Sarmiento, M.D., MPH on August 3, 2023 For treating patients…

MDNewsline DailyAugust 2, 2023

1 2 3 … 5 Next

Alopecia

U.S. Trends in Prevalence and Incidence of Alopecia Areata

Insights From the ‘All of Us’ Alopecia Research Program

Understanding Alopecia Areata Epidemiology in Hispanic/Latinx Patients

Understanding Causes of Racial Disparities in Alopecia Areata

Psychological Stress and the Development of Alopecia Areata

Ideal JAK Inhibitor for Alopecia Areata

Age and Sex Affect Alopecia Areata Comorbidities

Topical Steroids With Fractional Erbium YAG Laser in Alopecia Areata

Effectiveness and Safety of Ritlecitinib in Adolescents With Alopecia Areata

Treatment of Chronic Pruritus: Narrowband UVB vs. Broadband UVB

Categories

What’s New

Follow Us

Subscribe To Our Newsletter

About Us

Resources

Support